Search - tctmd.com

Displaying 801 - 820 of 1786

Sort: Relevancy | Date

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

ACDs Modestly Reduce Access Site Complications, Major Bleeding

September 15, 2014

Presentation TCT 2014

CTO PCI Potpourri: Complications (Especially Perforations), Radiation, and Contrast

Presenter: Mauro Carlino, Masahiko Ochiai, Stephen Cook

September 14, 2014

Presentation TCT 2014

Complications of Coronary, Peripheral, and Structural Interventions

Presenter: Morton J. Kern, Mauricio G. Cohen

September 14, 2014

Presentation TCT 2014

Valve Thrombus After TAVR: Frequency, Clinical Recognition, and Management

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib

September 14, 2014

Presentation TCT 2014

Anatomical and Procedural Factors Associated with Aortic Root Rupture During TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Marco Barbanti

September 14, 2014

Presentation TCT 2014

Risks, Consequences, and Treatment of Coronary Occlusion During TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Henrique B. Ribeiro

September 14, 2014

Presentation TCT 2014

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib

September 14, 2014

Presentation TCT 2014

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Tamim Nazif

September 14, 2014

Presentation TCT 2014

Bleeding Events (Early and Late) After TAVR: An Important and Often Misunderstood Complication

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Philippe Généreux

September 14, 2014

Presentation TCT 2014

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Michael J. Reardon

September 14, 2014

Presentation TCT 2014

Vascular Complications After TAVR: Changing Frequency, Clinical Impact, and Optimal Management

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Stephan Windecker

September 14, 2014

Presentation TCT 2014

TCT 685: Costs of Periprocedural Complications Among Patients Treated with a Self-Expanding Transcatheter Aortic Valve Prosthesis: Results from the CoreValve US Pivotal Extreme-Risk Study

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Suzanne Baron

September 14, 2014

Presentation TCT 2014

TCT 664: Cardiac Magnetic Resonance Versus Transthoracic Echocardiography for the Assessment and Quantification of Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Implantation

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Henrique B. Ribeiro

September 14, 2014

Presentation TCT 2014

Paravalvular Regurgitation After TAVR II: Will New TAVR Systems Eliminate the Problem?

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Ian T. Meredith

September 14, 2014

Presentation TCT 2014

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Susheel Kodali

September 14, 2014

Presentation TCT 2014

Neurocognitive Functional Assessment After TAVR: Methodologies and Clinical Importance

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Ronald M. Lazar

September 14, 2014

Presentation TCT 2014

Strokes After TAVR II: Management Considerations (Current and Future)

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Nicolas M. van Mieghem

September 14, 2014

Presentation TCT 2014

Strokes After TAVR I: Incidence (Past and Present) and Multifactorial Origin

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb

September 14, 2014

Presentation TCT 2014

Effectiveness of Arterial Closure Devices for Preventing Bleeding Complications After Transfermoral Percutaneous Coronary Intervention: A Controlled Instrumental Variable Analysis From The National Cardiovascular Data Registry

Presenter: Steven R. Bailey, Neil J Wimmer

September 14, 2014

Advertisement

Keynote Address Focuses on Newer DES, Problematic Subgroups

ACDs Modestly Reduce Access Site Complications, Major Bleeding

CTO PCI Potpourri: Complications (Especially Perforations), Radiation, and Contrast

Complications of Coronary, Peripheral, and Structural Interventions

Valve Thrombus After TAVR: Frequency, Clinical Recognition, and Management

Anatomical and Procedural Factors Associated with Aortic Root Rupture During TAVR

Risks, Consequences, and Treatment of Coronary Occlusion During TAVR

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Bleeding Events (Early and Late) After TAVR: An Important and Often Misunderstood Complication

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Vascular Complications After TAVR: Changing Frequency, Clinical Impact, and Optimal Management

TCT 685: Costs of Periprocedural Complications Among Patients Treated with a Self-Expanding Transcatheter Aortic Valve Prosthesis: Results from the CoreValve US Pivotal Extreme-Risk Study

TCT 664: Cardiac Magnetic Resonance Versus Transthoracic Echocardiography for the Assessment and Quantification of Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Implantation

Paravalvular Regurgitation After TAVR II: Will New TAVR Systems Eliminate the Problem?

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Neurocognitive Functional Assessment After TAVR: Methodologies and Clinical Importance

Strokes After TAVR II: Management Considerations (Current and Future)

Strokes After TAVR I: Incidence (Past and Present) and Multifactorial Origin

Effectiveness of Arterial Closure Devices for Preventing Bleeding Complications After Transfermoral Percutaneous Coronary Intervention: A Controlled Instrumental Variable Analysis From The National Cardiovascular Data Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content